Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-005583·SURMODICS INC
Schedule 13G ownership disclosure
SURMODICS INC
Common Stock, $0.05 par value per share · CUSIP: 868873100
Event date: 2025-01-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Soleus Capital Master Fund, L.P.
Shares: 739,060.00 · Class: 5.2%
- Soleus Capital, LLC
Shares: 739,060.00 · Class: 5.2%
- Soleus Capital Group, LLC
Shares: 739,060.00 · Class: 5.2%
- Soleus Capital Management, L.P.
Shares: 739,060.00 · Class: 5.2%
- Soleus GP, LLC
Shares: 739,060.00 · Class: 5.2%
- Guy Levy
Shares: 739,060.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-005583
- Form type
- SCHEDULE 13G
- Filer
- SURMODICS INC
- CIK
- CIK 924717
- Filed
- Jan 22, 2025
- Reporting period
- Jan 21, 2025
- Description
- Schedule 13G beneficial ownership